Product Information |
|
Registration Number |
DR-XY48073
|
Generic Name |
Azacitidine
|
Brand Name |
Xpreza
|
Dosage Strength |
100mg
|
Dosage Form |
Lyophilized Powder for Injection (I.V./S.C.)
|
Classification |
Prescription Drug (Rx)
|
Pharmacologic Category |
Antineoplastic (Pyrimidine Analogue)
|
Packaging |
50 mL-capacity clear and colorless glass vial with gray bromobutyl rubber stopper and aluminum seal with white plastic flip-off cap (box of l’s)
|
Manufacturer |
Natco Pharma Limited
|
Country of Origin |
India
|
Trader |
N/A
|
Importer |
Natco Lifesciences Philippines Inc.
|
Distributor |
Natco Lifesciences Philippines Inc.
|
Application Type |
Monitored Release (Reconstruction)
|
Issuance Date |
11 November 2022
|
Expiry Date |
31 May 2027
|